Enzyme Inhibitors

Subtype terms (34)

More specific conditions that are subtypes of Enzyme Inhibitors in the MeSH hierarchy.

• 5-Lipoxygenase-Activating Protein Inhibitors
• Acetaldehyde Dehydrogenase Inhibitors
• Adenosine Deaminase Inhibitors
• Adenylyl Cyclase Inhibitors
• Aromatic Amino Acid Decarboxylase Inhibitors
• beta-Lactamase Inhibitors
• Calcineurin Inhibitors
• Carbonic Anhydrase Inhibitors
• Catechol O-Methyltransferase Inhibitors
• Cholinesterase Inhibitors

  3 drugs approved

• Cyclooxygenase Inhibitors

  3 drugs approved

• Cytochrome P-450 Enzyme Inhibitors
• Folic Acid Antagonists
• Gamma Secretase Inhibitors and Modulators
• Glycoside Hydrolase Inhibitors
• Histone Deacetylase Inhibitors

  12 drugs (11 approved, 1 experimental)

• Hydroxymethylglutaryl-CoA Reductase Inhibitors

  10 drugs approved

• Integrase Inhibitors

  2 drugs approved

• Lipoxygenase Inhibitors
• Monoamine Oxidase Inhibitors

  1 drug experimental

• Nucleic Acid Synthesis Inhibitors
• Ornithine Decarboxylase Inhibitors
• Phosphodiesterase Inhibitors

  3 drugs (1 approved, 2 experimental)

• Phosphoinositide-3 Kinase Inhibitors
• Phospholipase A2 Inhibitors
• Poly(ADP-ribose) Polymerase Inhibitors

  6 drugs (4 approved, 2 experimental)

• Prolyl-Hydroxylase Inhibitors
• Protease Inhibitors

  5 drugs approved

• Protein Kinase Inhibitors

  13 drugs (8 approved, 5 experimental)

• Protein Synthesis Inhibitors
• Proton Pump Inhibitors

  9 drugs (8 approved, 1 experimental)

• Steroid Synthesis Inhibitors

  3 drugs approved

• Topoisomerase Inhibitors
• Uncoupling Agents

Drugs by status